A randomized trial of metronidazole in a single 2 g dose versus 500 mg twice daily for 7 days for the treatment of trichomoniasis in women

BACKGROUND: Trichomonias is the most common non-viral STI among women worldwide and is associated with serious reproductive morbidity, poor birth outcomes and amplified HIV transmission. Single-dose metronidazole therapy has been the treatment of choice for over three decades. There is mounting evid...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet Infect Dis
Hlavní autoři: Kissinger, Patricia, Muzny, Christina A., Mena, Leandro, Lillis, Rebecca A., Schwebke, Jane R., Beauchamps, Laura, Taylor, Stephanie N., Schmidt, Norine, Myers, Leann, Augostini, Peter, Secor, William E., Bradic, Martina, Carlton, Jane M., Martin, David H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6279510/
https://ncbi.nlm.nih.gov/pubmed/30297322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(18)30423-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky